Fir Tree Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
CI
APM
HIIFS
Fir Tree Capital Management's XBI Position: Q2 2022 in Review
Fir Tree Capital Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2022, closing a stake of 215,000 shares — an estimated $19.3M sold.
Fir Tree Capital Management first reported a position in XBI in Q3 2021 and held it in 3 quarters. The position peaked at $25.2M in Q4 2021. 706 funds tracked by Wall St. Rank hold XBI as of Q2 2022.
- Fir Tree Capital Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2022 after selling out during the quarter.
- Fir Tree Capital Management sold 215,000 State Street SPDR S&P Biotech ETF shares in Q2 2022, an estimated $19.3M.
- Fir Tree Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2021 and held it in 3 quarters.
- Fir Tree Capital Management's State Street SPDR S&P Biotech ETF position peaked at $25.2M in Q4 2021.
- 706 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2022.
Based on Fir Tree Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.